Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs VanEck Junior Gold Miners (GDXJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs VanEck Junior Gold Miners — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.04 (market cap $3.94B), while VanEck Junior Gold Miners trades at $105.8 (market cap $8.21B). The key difference: VanEck Junior Gold Miners is far larger — about 2.1× Edgewise Therapeutics Inc. Common Stock's market cap, and Edgewise Therapeutics Inc. Common Stock is trading nearer its 52-week high, VanEck Junior Gold Miners nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and VanEck Junior Gold Miners for 41 Days on average.
| EWTX | GDXJ | |
|---|---|---|
Market Cap | $3.94B | $8.21B |
Volume | 810,104 | 2,596,073 |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $48.35 | $156.19 |
52-Week Low | $14.89 | $87.56 |
Typical Hold Time | 0 Days | 41 Days |
Enterprise Value | $3.48B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
GDXJ, the VanEck Junior Gold Miners ETF, trades at $110.63, down 2.03% on the day amid a bearish technical signal from moving averages. Recent news highlights multiple junior mining companies being added to the ETF's index, potentially increasing its diversification and investor interest. Key technical indicators show mixed signals, with oscillators neutral but moving averages and overall signal leaning bearish.
The outlook for GDXJ is influenced by gold price volatility and the performance of its underlying junior mining holdings. Investment opportunities include exposure to gold's potential upside through leveraged junior miners, but risks involve sector-specific volatility, operational challenges of small-cap miners, and broader market sentiment shifts affecting gold prices.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About VanEck Junior Gold Miners
GDXJ provides exposure to small and mid-cap companies in the global gold and silver mining industry. It focuses on 'junior' miners involved in exploration and early production, featuring 2026 leaders like Pan American Silver and Coeur Mining.
Read more on GDXJ →
